Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1999-2-24
|
pubmed:abstractText |
The objective of this study was to investigate the effect of follicle stimulating hormone (FSH) priming on the in-vitro maturation (IVM) of human oocytes from healthy ovaries using a chemically defined culture system. Seventeen patients donating oocytes for research received a truncated course of 600 IU FSH over 5 days and a further control group of nine patients received no FSH treatment. Mid-follicular phase cumulus-enclosed oocytes (n = 160) were aspirated from follicles < or =4 mm diameter under transvaginal ultrasound guidance and were cultured for 48 h in microdrops of medium containing 10 mIU/ml FSH and 100 mIU/ ml human chorionic gonadotrophin (HCG). The results demonstrated that human oocytes will efficiently undergo IVM under serum-free conditions. After mild FSH stimulation, a greater number of cumulus-enclosed oocytes was collected, and following culture, a lower rate of degeneration was observed. Significantly more oocytes completed nuclear maturation to metaphase II following FSH stimulation (71.1 versus 43.5%). In conclusion, a truncated course of FSH stimulation in vivo improved the oocyte maturation rate in vitro, giving a mean of 4.8+/-0.7 metaphase II oocytes per patient compared with only 2.1+/-0.7 from control patients, thus yielding more mature oocytes for future IVF treatment.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chorionic Gonadotropin,
http://linkedlifedata.com/resource/pubmed/chemical/Culture Media,
http://linkedlifedata.com/resource/pubmed/chemical/Culture Media, Serum-Free,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/Estradiol,
http://linkedlifedata.com/resource/pubmed/chemical/Follicle Stimulating Hormone
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0268-1161
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3132-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9853870-Adult,
pubmed-meshheading:9853870-Cell Count,
pubmed-meshheading:9853870-Cells, Cultured,
pubmed-meshheading:9853870-Chorionic Gonadotropin,
pubmed-meshheading:9853870-Culture Media,
pubmed-meshheading:9853870-Culture Media, Serum-Free,
pubmed-meshheading:9853870-DNA,
pubmed-meshheading:9853870-Estradiol,
pubmed-meshheading:9853870-Female,
pubmed-meshheading:9853870-Follicle Stimulating Hormone,
pubmed-meshheading:9853870-Follicular Phase,
pubmed-meshheading:9853870-Humans,
pubmed-meshheading:9853870-Metaphase,
pubmed-meshheading:9853870-Oocytes,
pubmed-meshheading:9853870-Suction,
pubmed-meshheading:9853870-Time Factors
|
pubmed:year |
1998
|
pubmed:articleTitle |
Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation.
|
pubmed:affiliation |
Assisted Conception Unit, University of Leeds, West Yorkshire, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|